Latest News

The Ratings Game: Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout

24 views0
By
Share

[#item_full_content]

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
Previous
Next

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News